HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.

Abstract
Although recent studies have indicated roles of long non-coding RNAs (lncRNAs) in physiological aspects of cell-type determination and tissue homeostasis, their potential involvement in regulated gene transcription programs remains rather poorly understood. The androgen receptor regulates a large repertoire of genes central to the identity and behaviour of prostate cancer cells, and functions in a ligand-independent fashion in many prostate cancers when they become hormone refractory after initial androgen deprivation therapy. Here we report that two lncRNAs highly overexpressed in aggressive prostate cancer, PRNCR1 (also known as PCAT8) and PCGEM1, bind successively to the androgen receptor and strongly enhance both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells. Binding of PRNCR1 to the carboxy-terminally acetylated androgen receptor on enhancers and its association with DOT1L appear to be required for recruitment of the second lncRNA, PCGEM1, to the androgen receptor amino terminus that is methylated by DOT1L. Unexpectedly, recognition of specific protein marks by PCGEM1-recruited pygopus 2 PHD domain enhances selective looping of androgen-receptor-bound enhancers to target gene promoters in these cells. In 'resistant' prostate cancer cells, these overexpressed lncRNAs can interact with, and are required for, the robust activation of both truncated and full-length androgen receptor, causing ligand-independent activation of the androgen receptor transcriptional program and cell proliferation. Conditionally expressed short hairpin RNA targeting these lncRNAs in castration-resistant prostate cancer cell lines strongly suppressed tumour xenograft growth in vivo. Together, these results indicate that these overexpressed lncRNAs can potentially serve as a required component of castration-resistance in prostatic tumours.
AuthorsLiuqing Yang, Chunru Lin, Chunyu Jin, Joy C Yang, Bogdan Tanasa, Wenbo Li, Daria Merkurjev, Kenneth A Ohgi, Da Meng, Jie Zhang, Christopher P Evans, Michael G Rosenfeld
JournalNature (Nature) Vol. 500 Issue 7464 Pg. 598-602 (Aug 29 2013) ISSN: 1476-4687 [Electronic] England
PMID23945587 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • PCGEM1 non-coding RNA, human
  • RNA, Long Noncoding
  • Receptors, Androgen
  • Transcription Factors
Topics
  • Animals
  • Castration
  • Cell Line, Tumor
  • Cell Proliferation
  • Enhancer Elements, Genetic (genetics)
  • Humans
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Promoter Regions, Genetic (genetics)
  • Prostatic Neoplasms (genetics, pathology)
  • RNA, Long Noncoding (genetics)
  • Receptors, Androgen (metabolism)
  • Transcription Factors (metabolism)
  • Transcriptional Activation (genetics)
  • Up-Regulation (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: